GenBioPro Sues FDA to Keep Generic Mifepristone on the Market

“Once a drug has been through the rigorous FDA review process and received approval, federal law protects the right to market the drug,” said GenBioPro CEO Evan Massingill. “GenBioPro will use all regulatory and legal tools to protect access to mifepristone for patients and providers.”

the U.S. Food and Drug Administration on Wednesday, April 19, in Maryland federal court, where the agency is headquartered. The suit seeks an order to compel the FDA to allow GenBioPro to continue to sell the medication in the United States. GenBioPro estimates their generic medication comprises two-thirds of the mifepristone in the United States.in a Texas case that attempt to remove the medication from the market.

GenBioPro argued the company has the right to preserve the drug’s availability under the federal Food, Drug and Cosmetic Act , the FDA’s regulations and the company’s constitutional rights guaranteed by the Fifth Amendment of the United States Constitution.

Good!

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on marketThe Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »

As Supreme Court Weighs Next Steps on Abortion Pill, Protesters Rally and Pharma Company GenBioPro Sues FDA to Restore AccessAs the Supreme Court weighs its options on the abortion pill mifepristone, abortion and women’s rights supporters across the U.S. are protesting the latest efforts to restrict access to abortion.
출처: MsMagazine - 🏆 378. / 59 더 많은 것을 읽으십시오 »

Abortion pill manufacturer sues FDA to keep drug on the marketThe Supreme Court is expected to rule today on whether to impose restrictions to abortion pills. Eugene_Scott Did Ron DeSantis tell you to fire them?
출처: axios - 🏆 302. / 63 더 많은 것을 읽으십시오 »